| pubmed-article:11326664 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11326664 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:11326664 | lifeskim:mentions | umls-concept:C0025202 | lld:lifeskim |
| pubmed-article:11326664 | lifeskim:mentions | umls-concept:C0229671 | lld:lifeskim |
| pubmed-article:11326664 | lifeskim:mentions | umls-concept:C0041365 | lld:lifeskim |
| pubmed-article:11326664 | lifeskim:mentions | umls-concept:C1417154 | lld:lifeskim |
| pubmed-article:11326664 | pubmed:issue | 6D | lld:pubmed |
| pubmed-article:11326664 | pubmed:dateCreated | 2001-4-30 | lld:pubmed |
| pubmed-article:11326664 | pubmed:abstractText | Reports published in 1996 concerning the protein MIA proposed it as a useful tumor marker for patients suffering from malignant melanoma. Therefore we systematically started to measure MIA levels in patients with malignant melanoma. It was and still is questionable whether MIA in the serum of melanoma patients is a reliable tumor marker in terms of course of disease, therapy-monitoring and prognostic value. Previous studies have already confirmed the specifity of MIA as a tumor marker for malignant melanoma. | lld:pubmed |
| pubmed-article:11326664 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11326664 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11326664 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11326664 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11326664 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11326664 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11326664 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11326664 | pubmed:issn | 0250-7005 | lld:pubmed |
| pubmed-article:11326664 | pubmed:author | pubmed-author:RingJJ | lld:pubmed |
| pubmed-article:11326664 | pubmed:author | pubmed-author:HeinRR | lld:pubmed |
| pubmed-article:11326664 | pubmed:author | pubmed-author:BüttnerRR | lld:pubmed |
| pubmed-article:11326664 | pubmed:author | pubmed-author:BosserhoffAA | lld:pubmed |
| pubmed-article:11326664 | pubmed:author | pubmed-author:GaugerAA | lld:pubmed |
| pubmed-article:11326664 | pubmed:author | pubmed-author:StahleckerJJ | lld:pubmed |
| pubmed-article:11326664 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11326664 | pubmed:volume | 20 | lld:pubmed |
| pubmed-article:11326664 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11326664 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11326664 | pubmed:pagination | 5041-4 | lld:pubmed |
| pubmed-article:11326664 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:11326664 | pubmed:meshHeading | pubmed-meshheading:11326664... | lld:pubmed |
| pubmed-article:11326664 | pubmed:meshHeading | pubmed-meshheading:11326664... | lld:pubmed |
| pubmed-article:11326664 | pubmed:meshHeading | pubmed-meshheading:11326664... | lld:pubmed |
| pubmed-article:11326664 | pubmed:meshHeading | pubmed-meshheading:11326664... | lld:pubmed |
| pubmed-article:11326664 | pubmed:meshHeading | pubmed-meshheading:11326664... | lld:pubmed |
| pubmed-article:11326664 | pubmed:meshHeading | pubmed-meshheading:11326664... | lld:pubmed |
| pubmed-article:11326664 | pubmed:meshHeading | pubmed-meshheading:11326664... | lld:pubmed |
| pubmed-article:11326664 | pubmed:meshHeading | pubmed-meshheading:11326664... | lld:pubmed |
| pubmed-article:11326664 | pubmed:meshHeading | pubmed-meshheading:11326664... | lld:pubmed |
| pubmed-article:11326664 | pubmed:meshHeading | pubmed-meshheading:11326664... | lld:pubmed |
| pubmed-article:11326664 | pubmed:meshHeading | pubmed-meshheading:11326664... | lld:pubmed |
| pubmed-article:11326664 | pubmed:meshHeading | pubmed-meshheading:11326664... | lld:pubmed |
| pubmed-article:11326664 | pubmed:articleTitle | MIA as a reliable tumor marker in the serum of patients with malignant melanoma. | lld:pubmed |
| pubmed-article:11326664 | pubmed:affiliation | Klinik und Poliklinik für Dermatologie und Allergologie am Biederstein, Technische Universität München, Germany. | lld:pubmed |
| pubmed-article:11326664 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11326664 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11326664 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11326664 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11326664 | lld:pubmed |
